N/A N=180 Efficacy Trial of a Dissonance Based Eating Disorder Program
Eating Disorder
Primary: Rosenberg Self-Esteem Scale (RSE). — 22.71; 22.50; 22.62 units on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=55 Eating Disorder Prevention Program for Women With T1D
Eating Disorders · Type 1 Diabetes
Primary: Percentage of Time With Blood Sugar in Range as a Measure of Glycemic Control — 0.61; 0.63 percentage of time
N/A N=159 Development of Eating Disorders Symptoms Among Children
Eating Disorders Symptoms
Primary: Number of Participants With >20 on the 26 Children Eating Attitudes Test — 26; 4 Participants
N/A N=50 Cognitive Behavioral Therapy for Adolescent Binge Eating and Loss of Control Eating
Binge Eating · Eating Disorders in Adolescence · Overweight and Obesity
Primary: Binge (Loss-of-control) Eating Episode Frequency — 1.52; 6.05 episodes of behavior — p=.01
Phase 1 N=148 Leveraging Social Media to Identify and Connect Teens With Eating Disorders to a Mobile Guided Self-Help Mobile Intervention
Eating Disorders
Primary: Eating Disorder Psychopathology — 3.75; 3.93; 3.71; 3.50 EDE-Q Global score — p=0.90
N/A N=117 Multi-Family Group Therapy for Adult Eating Disorders
Eating Disorders
Primary: Dropout — 17; 18 participants
N/A N=100 Self-Control in Bulimia Nervosa
Bulimia Nervosa
Primary: Brain Activation Associated With P(Stop) — 0.02; 0.11; 0.04; 0.05 BOLD Signal
N/A N=205 Treatment Uptake Chatbot for Eating Disorders
Eating Disorders
Primary: Rates of Treatment/Services Utilization for Eating, Shape, or Weight Concerns Among All Participants Randomized to the Intervention Following Online Eating Disorder…
Early Phase 1 N=13 Dopamine Receptor Contributions to Prediction Error and Reversal Learning in Anorexia Nervosa
Anorexia Nervosa
Primary: Measurement of Brain Activation (Measured in Percent Signal Change) During a Prediction Error Taste Reward Task Using Functional Magnetic Resonance Imaging (fMRI)…
N/A N=177 Shifting Perspectives: Enhancing Outcomes in Anorexia Nervosa With CRT
Anorexia Nervosa
Primary: Change in Cognitive Flexibility - Condition 4 Trail Making Test of DKEFS — 11.89; 10.94; 11.47; 11.14 score on a scale — p=.507
N/A N=99 Fear, Gastrointestinal Distress, and Interoception: Physiological and Psychological Mechanisms in Eating Disorders
Feeding and Eating Disorders
Primary: Subjective Rating of Fear — -36.9444; -23.9219; -47.3611; 85.6250 units on scale*minutes — p=.879
N/A N=90 Helping HAND: Healing Anorexia Nervosa Digitally
Anorexia Nervosa
Primary: Effectiveness of the Mobile App Conditions, Compared to Referral to Usual Care, in Changing Eating Disorder Psychopathology, as Assessed by the Eating Disorder…
N/A N=24 MUMMIBODIES. Eating Disorders, Pregnancy and Post Partum Period.
Mental Health Disorder · Eating Disorders · Pregnancy Related
Primary: Number of Participants With Each Type of Personal Features Associated With Worsening or Relapse of Eating Disorder Symptoms During Pregnancy (Time Point 1) — 5; 3; 3; 4…
Phase 4 N=41 A Double-blind, Placebo Controlled Trial of Risperidone for the Treatment of Anorexia Nervosa
Anorexia Nervosa
Primary: Change in Eating Disorder Inventory-2 Drive for Thinness Subscale (DT) — 1.36; 3.93 units on a scale
N/A N=481 Efficacy of the Female Athlete Body Project (FAB)
Eating Disorders · Female Athlete Triad
Primary: Eating Disorder Examination Questionnaire (EDE-Q) — .98; 1.24; .54; .84 units on a scale
Phase 4 N=88 Monoamine Contributions to Neurocircuitry in Eating Disorders
Eating Disorder
Primary: 5-HT Transporter Binding as Measured During the PET Scan — 1.68; 1.54; 1.46; 1.60 binding potential (BPND) — p=> 0.05
N/A N=32 A One-Day ACT Workshop for Emotional Eating
Emotional Eating · Eating Behavior
Primary: Emotional Eating - 2-weeks Post-intervention — 3.27 units on a scale
N/A N=71 An fMRI Study of Self-regulation in Adolescents With Bulimia Nervosa
Eating Disorders
Primary: Magnetic Resonance Imaging Scans — 2.98; 2.96 mm — p=.03
N/A N=40 Escitalopram Treatment of Night Eating Syndrome
Night Eating Syndrome
Primary: Night Eating Questionnaire — -13.0; -10.6 units on a scale
N/A N=126 Improving Weight Loss Outcomes for Binge Eating Disorder.
Eating Disorder · Binge-Eating Disorder · Weight Loss
Primary: Weight Loss — 0; 0; -2.13; -2.15 percentage of weight loss
N/A N=102 Binge Eating Disorder Treatment Study
Binge Eating Disorder
Primary: Frequency of Binge Eating in the Past 28 Days — 16.06; 14.48; 6.26; 7.40 days
Phase 2 N=10 Neurobiology of Bulimia Nervosa
Bulimia Nervosa
Primary: Change in Binge Eating Sum Score — -0.60; 0.89 score on a scale
N/A N=152 Olanzapine Versus Placebo for Outpatients With Anorexia Nervosa
Anorexia Nervosa
Primary: Rate of Weight Change — 0.095; 0.260 kg/m^2 per month
N/A N=20 Binge Eating Syndrome Treatment for Older Women (BESTOW)
Binge Eating
Primary: Feasibility - Usage Rating Profile - Intervention — 5.44; 5.53 score on a scale
N/A N=109 Weight Loss Treatment for Veterans With Binge Eating
Binge Eating Disorder
Primary: Change in Eating Disorder Examination-Self-report Questionnaire (EDE-Q) — 3.18; 2.89; 2.81; 2.13 score on a scale
N/A N=300 Psychopathology, Disordered Eating, and Impulsivity as Predictors of Outcomes of Bariatric Surgery
Obesity
Primary: Percent Weight Change — 23.0; 26.2; 23.3 percent weight change
N/A N=85 Optimizing Provider Training in Eating Disorders (OPTED)
Anorexia Nervosa · Atypical Anorexia Nervosa
Primary: Number of Participants Who Complete Training — 48; 22; 8; 7 Participants — p=0.47
N/A N=30 Effect of Managing Problematic Eating Behaviours With Dietary Management on Chronic Disease Self-management
Hypertension · Type 2 Diabetes
Primary: The Change in EEQ (Emotional Eater Questionnaire) Score is the Primary Outcome Measure in This Study. — -1.7; -3.2 Scores on a scale
Phase 3 N=528 Dasotraline Binge Eating Disorder Extension Study
Binge Eating Disorder
Primary: Frequency and Severity of Suicidal Ideation Using the Columbia-suicide Severity Rating Scale (C-SSRS) — 515; 7; 3; 1 Participants
Phase 3 N=486 A Study to Evaluate a Drug (Dasotraline) on the Safety, Effectiveness and How Well the Body Tolerates it, in Adults With Moderate to Severe Binge Eating Disorder
Binge Eating Disorder
Primary: Change From Baseline in Number of Binge Days — -2.92; -3.21; -3.47 binge days/week — p=0.1187